Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,254.00    6.00 (0.14%)
Bid:
4,256.00
Ask:
4,260.00
Spread: 4.00 (0.094%)
Market Cap: £4.46b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Directorate Change

20 Oct 2022 10:30

RNS Number : 5557D
Computacenter PLC
20 October 2022
 

Computacenter plc

Incorporated in England and Wales

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

FOR IMMEDIATE RELEASE

 

Computacenter plc

 

Directorate Change

 

 

Computacenter plc (the "Company") is pleased to announce the appointment of René Carayol to the Board as an Independent Non-Executive Director with effect from Tuesday 1 November 2022.

 

After leaving University, René joined Marks & Spencer where he worked for 10 years, including as a Senior IT Manager, before moving to join PepsiCo as IT Systems Director. He subsequently moved to IPC Magazines as CIO, staying with the business until it was sold to AOL Time Warner. René is now an experienced Executive Leadership Coach and broadcaster, with much of his recent work focusing particularly on areas such as Diversity and Inclusion, Inclusive Leadership and cultural transformation across large organisations.

 

In 2004, René was awarded an MBE for his outstanding contribution to the business community. He holds an undergraduate degree from the London School of Economics and Political Science and was awarded an Honorary Doctorate by the University of Roehampton. René will serve as a member of the Audit, Nomination and Remuneration Committees.

 

Rene Haas has informed the Company that he will retire from the Board with effect from Thursday 1 December 2022.

 

Peter Ryan, Chair, commented:

 

"I am pleased to welcome René Carayol to our Board. He has had a long, successful and varied career and his experience will be a meaningful addition to our Board team. I would also like to thank Rene Haas for the valuable contributions he has made during his tenure as a Non-Executive Director."

 

Note:

 

This announcement is made pursuant to Listing Rule 9.6.11. In accordance with LR 9.6.13R of the Listing Rules, Computacenter confirms that there is no information to be disclosed in terms of LR 9.6.13R (2) to LR 9.6.13R (6) inclusive in respect of René Carayol.

 

Enquiries:

 

Computacenter plc

 

Mike Norris, Chief Executive

 

01707 631601

Tony Conophy, Finance Director

01707 631515

 

Tulchan Communications

 

James Macey White/ Matt Low

020 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURAKRUVURURA
Date   Source Headline
14th Sep 20204:15 pmRNSDirector/PDMR Shareholding
11th Sep 202011:00 amRNSDirector/PDMR Shareholding
9th Sep 20207:00 amRNSArrangement Agreement to Acquire IT Solutions Firm
9th Sep 20207:00 amRNSHalf-year Report
2nd Sep 20207:00 amRNSTrading Statement
6th Aug 20201:15 pmRNSBlock listing Interim Review
22nd Jul 20207:00 amRNSH1 2020 Trading Statement
15th May 20207:00 amRNSTrading Statement
14th May 20202:00 pmRNSResult of AGM
30th Apr 20205:00 pmRNSDirector/PDMR Shareholding
27th Apr 20203:31 pmRNSDisclosure of Rights Attaching to Equity Shares
27th Apr 202011:21 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSQ1 2020 Trading Update
9th Apr 20207:00 amRNS2019 Annual Report & Notice of 2020 AGM
6th Apr 20205:45 pmRNSDirector Remuneration
3rd Apr 20207:00 amRNSDirector Declaration
25th Mar 20205:00 pmRNSDirector/PDMR Shareholding
25th Mar 20204:45 pmRNSDirector/PDMR Shareholding
24th Mar 20202:00 pmRNSDirector Declaration
24th Mar 20209:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results 2019
6th Feb 20209:31 amRNSBlock listing Interim Review
23rd Jan 20207:00 amRNSPre-Close Trading Statement
17th Dec 201910:15 amRNSDirector/PDMR Shareholding
13th Dec 201910:16 amRNSNotification of Major Interest in Shares
10th Dec 20197:00 amRNSTrading Statement
4th Dec 201911:01 amRNSDirector/PDMR Shareholding
3rd Dec 20199:17 amRNSDirector/PDMR Shareholding
1st Nov 20197:00 amRNSNotification of Major Interest in Shares
30th Oct 20197:00 amRNSQ3 2019 Trading Update
23rd Oct 20193:45 pmRNSDirector/PDMR Shareholding
29th Aug 20194:30 pmRNSNotification of Major Interest in Shares
28th Aug 201910:26 amRNSDirector/PDMR Shareholding
23rd Aug 20197:00 amRNSHalf-year Report
20th Aug 20194:30 pmRNSDirectorate Change
14th Aug 20195:06 pmRNSNotification of Major Interest in Shares
6th Aug 201910:33 amRNSBlock listing Interim Review
1st Aug 20194:39 pmRNSNotification of Major Interest in Shares
31st Jul 20197:00 amRNSH1 2019 Trading Statement
29th May 20196:00 pmRNSDirector/PDMR Shareholding
16th May 20196:00 pmRNSDirectorate Change
16th May 201911:00 amRNSDirectorate Change
16th May 201910:00 amRNSResult of AGM
9th May 20195:30 pmRNSDirector/PDMR Shareholding
26th Apr 20197:00 amRNSQ1 2019 Trading Update
17th Apr 20199:45 amRNSDirector/PDMR Shareholding
12th Apr 20197:00 amRNS2018 Annual Report & Notice of 2019 AGM
4th Apr 20199:45 amRNSDirector Declaration
25th Mar 20194:30 pmRNSDirector/PDMR Shareholding
25th Mar 201912:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.